Assignee
GOLDSTEIN GLENN A
US·6 granted patents·12 pending applications·194 citations·filing 1987–2019
Top patents by PatentIndex Score
18 records- 0196US9216162B2N-acetylcysteine amide (NAC amide) in the treatment of diseases and conditions associated with oxidative stressGOLDSTEIN GLENN A·Filed 2015·Granted Dec 22, 2015·13 cites·25 claims
- 0293US10869846B2N-acetylcysteine amide (NAC amide) in the treatment of diseases and conditions associated with oxidative stressGOLDSTEIN GLENN A·Filed 2018·Granted Dec 22, 2020·5 cites·15 claims
- 0391US8937099B2N-acetylcysteine amide (NAC amide) for the treatment of diseases and conditions associated with oxidative stressGOLDSTEIN GLENN A·Filed 2010·Granted Jan 20, 2015·15 cites·21 claims
- 0490US8354449B2N-acetylcysteine amide (NAC amide) for the treatment of diseases and conditions associated with oxidative stressGOLDSTEIN GLENN A·Filed 2010·Granted Jan 15, 2013·14 cites·8 claims
- 0590US5240308AErgonomic adjustable chair and methodGOLDSTEIN GLENN A·Filed 1991·Granted Aug 31, 1993·95 cites·4 claims
- 0678US5018786AErgonomic adjustable chair and methodGOLDSTEIN GLENN A·Filed 1987·Granted May 28, 1991·52 cites·10 claims
- 0765US2017135970A1N-acetylcysteine amide (nac amide) in the treatment of diseases and conditions associated with oxidative stressGOLDSTEIN GLENN A·Filed 2016·Application pending·0 cites
- 0863US2016206576A1N-acetylcysteine amide (nac amide) in the treatment of diseases and conditions associated with oxidative stressGOLDSTEIN GLENN A·Filed 2015·Application pending·0 cites
- 0963US2020170968A1Use of N-Acetylcysteine Amide in the Treatment of Acquired Immune Deficiency Syndrome and HIV InfectionGOLDSTEIN GLENN A·Filed 2019·Application pending·0 cites
- 1062US2020069617A1Use of n-acetylcysteine amide in the treatment of acetaminophen overdoseGOLDSTEIN GLENN A·Filed 2019·Application pending·0 cites
- 1159US2019151262A1Use of n-acetylcysteine amide for decreasing intracranial pressureGOLDSTEIN GLENN A·Filed 2018·Application pending·0 cites
- 1255US2009234011A1N-acetylcysteine amide (nac amide) for the treatment of diseases and conditions associated with oxidative stressGOLDSTEIN GLENN A·Filed 2006·Application pending·0 cites
- 1353US2008274888A1N-Acetylcysteine Amide (Nac Amide) for Enhancing Plant Resistance and Tolerance to Environmental StressGOLDSTEIN GLENN A·Filed 2006·Application pending·0 cites
- 1453US2015133558A1Use of n-acetylcysteine amide for decreasing intracranial pressureGOLDSTEIN GLENN A·Filed 2014·Application pending·0 cites
- 1553US2017000747A1Use of n-acetylcysteine amide in the treatment of acetaminophen overdoseGOLDSTEIN GLENN A·Filed 2016·Application pending·0 cites
- 1651US2008200548A1N-Acetylcysteine Amide (Nac Amide) for Treatment of Oxidative Stress Associated with InfertilityGOLDSTEIN GLENN A·Filed 2006·Application pending·0 cites
- 1742US2010137676A1N-acetylcysteine amide (nac amide) for treatment of oxidative stress associated with infertilityGOLDSTEIN GLENN A·Filed 2010·Application pending·0 cites
- 1840US2017049727A1Use of N-Acetylcysteine Amide in the Treatment of Acquired Immune Deficiency Syndrome and HIV InfectionGOLDSTEIN GLENN A·Filed 2015·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →